Combining 5‐azacitidine with the E‐selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia
Article in British Journal of Haematology (April 2024)
The most recent citing publications are shown below. View all 105 publications that cite this research output on Dimensions.
Article in British Journal of Haematology (April 2024)
Article in Carbohydrate Research (April 2024)
Article in Angiogenesis (March 2024)